Please Wait.....
Report
Global Lung Cancer Screening Market Report and Forecast 2024-2032
Market Report (7 days) I 2024-02-12 I 180 Pages I EMR Inc.
Global Lung Cancer Screening Market Report and Forecast 2024-2032
Global Lung Cancer Screening Market Outlook
The global lung cancer screening market size was valued at USD 2.5 billion in 2023, driven by increasing prevalence of lung cancer. The market size is anticipated to grow at a CAGR of 8.2% during the forecast period of 2024-2032 to achieve a value of USD 5.1 billion by 2032.
Lung Cancer Screening: Introduction
Lung cancer screening is a medical procedure used to detect lung cancer in its early stages, particularly among high-risk individuals, such as long-term smokers. The most common method is low-dose computed tomography (LDCT), a type of X-ray that provides detailed images of the lungs, enabling the detection of small nodules or abnormalities that may indicate early-stage lung cancer. Early detection through screening is crucial as it significantly improves treatment success rates and overall patient survival.
Key Trends in the Global Lung Cancer Screening Market
Increasing focus on personalized treatment plans based on genetic profiling of tumors, allowing for more targeted and effective therapies. Breakthroughs in immunotherapy are providing new hope, with treatments that help the immune system recognize and fight cancer cells more effectively.
Enhanced emphasis on early detection through advanced screening technologies like low-dose CT scans, aiming to diagnose lung cancer at more treatable stages. Growing trend towards using a combination of treatment methods, including surgery, radiation, chemotherapy, and targeted therapies, to improve patient outcomes.
Integration of digital tools and AI in diagnostics, treatment planning, and patient monitoring, aiming to optimize treatment paths and improve prognostic evaluations. Increased availability of support services focusing on the mental and emotional well-being of patients and their families, recognizing the importance of holistic care in cancer treatment.
Evolving regulatory policies and reimbursement models to support the adoption of innovative treatments and ensure patients have access to the latest and most effective therapies.
Global Lung Cancer Screening Market Segmentation
Market Breakup by Type
- Low dose computed tomography (LDCT)
- X-ray
Market Breakup by Age Group
- 50 and older
- Below 50
Market Breakup by End User
- Hospitals
- Diagnostic Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Lung Cancer Screening Market Overview
In North America, the lung cancer market is highly advanced with a strong emphasis on early detection and cutting-edge treatment options. There is a significant focus on lung cancer screening programs, particularly using low dose computed tomography (LDCT), to catch the disease at a more treatable stage. The region also sees a high adoption rate of targeted therapies and immunotherapies, reflecting its robust pharmaceutical and biotechnology sectors.
Europe's lung cancer market is characterized by comprehensive healthcare systems and substantial government support for healthcare research. The region has strict tobacco control policies contributing to prevention efforts. There's a strong focus on integrating advanced diagnostics, including molecular biomarker testing, to guide targeted treatment approaches. Additionally, Europe is a hub for clinical trials, aiming to develop and approve innovative therapies.
The lung cancer market in the Asia Pacific region is rapidly growing, driven by increasing healthcare expenditure and a rising incidence of lung cancer. The market is diverse, with countries at various stages of healthcare infrastructure development. There's a growing emphasis on improving healthcare facilities, increasing public awareness about cancer prevention and early detection, and adopting modern treatment modalities. Countries like Japan and South Korea are leading in technological adoption, while others are progressively enhancing their healthcare systems to provide better cancer care.
Global Lung Cancer Screening Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Canon Medical Systems
- Eon Health
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- Medtronic Plc
- Microsoft Corporation (Nuance Communications, Inc)
- Penrad Technologies Inc.
- Miltenyi Biotech
- Volpara Solutions Limited.
- General Electric
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Lung Cancer Screening Market Overview
3.1 Global Lung Cancer Screening Market Historical Value (2017-2023)
3.2 Global Lung Cancer Screening Market Forecast Value (2024-2032)
4 Global Lung Cancer Screening Market Landscape
4.1 Global Lung Cancer Screening: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Lung Cancer Screening: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Lung Cancer Screening Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Lung Cancer Screening Market Segmentation
6.1 Global Lung Cancer Screening Market by Type
6.1.1 Market Overview
6.1.2 Low Dose Computed Tomography (LDCT)
6.1.3 X-ray
6.2 Global Lung Cancer Screening Market by Age group
6.2.1 Market Overview
6.2.2 50 and older
6.2.3 Below 50
6.3 Global Lung Cancer Screening Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Diagnostic Centers
6.3.4 Others
6.4 Global Lung Cancer Screening Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Lung Cancer Screening Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Lung Cancer Screening Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Lung Cancer Screening Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Lung Cancer Screening Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Lung Cancer Screening Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Canon Medical Systems
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Eon Health
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Fujifilm Holdings Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Koninklijke Philips N.V.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Medtronic Plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Microsoft Corporation (Nuance Communications, Inc)
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Penrad Technologies Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Miltenyi Biotec
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Volpara Solutions Limited.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 General Electric
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security